US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 3.2600
  • +0.1300+4.15%
Close Nov 18 16:00 ET
  • 3.2600
  • 0.00000.00%
Post 20:01 ET
12.44MMarket Cap-483P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2023/H1 0.000 / 0.000 --
-- 2022/H2 0.000 / 0.000 --
-- 2022/H1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

NLS Pharmaceutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 16 06:03

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 13 05:06

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 5 21:01

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 23 04:04

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data